AKT1 and lung cancer: Citrate can act on the IGF-1R-AKT-PTEN-eIF2a pathway to inhibit the growth of A549 lung cancer, and metabolic profile analysis has shown that it inhibits glycolysis and the tricarboxylic acid cycle in tumor cells both in vivo and in vitro (31).